October 6, 2022 – NCI AND RUTGERS UNIVERSITY OPEN PHASE 1 CLINICAL TRIALS OF T CELL RECEPTOR THERAPY TARGETING KK-LC-1 FOR MULTIPLE SOLID TUMORS

LOS ANGELES, CA – October 6, 2022 - T-Cure [...]